Today, Siemens Healthcare and the Cardio-Thoracic Center of Monaco (CCM) signed a partnership contract in Monaco. Within the framework of this contract, CCM was nominated the first “Siemens European Reference Center Cardiovascular Medicine".
The strategic partnership is dedicated to the entire spectrum of cardiovascular medicine with the objective to develop innovative solutions for the treatment of patients suffering from cardiovascular diseases. The effects of Siemens medical technologies on the quality and efficiency of diagnosis and therapy are already today reflected at the CCM. In the future, the reference center will also serve as an international training and visitors' platform that demonstrates optimized clinical workflows and advanced multi-modality imaging to healthcare providers.
The Cardio-Thoracic Center of Monaco is a hospital of 50 beds specialized in the medical and surgical treatment of cardio-thoracic and vascular diseases. Recognized for its advanced treatment methods and modern equipment, the hospital is highly regarded in its field. Of international scope, the CCM treats patients from all over the world and allows physicians to access international fellowship programs – a training on the most modern diagnostic and therapeutic technologies.
Compared to more conventional medical institutions CCM foregoes department-specific structures. Since its creation in 1987, multidisciplinary cooperation has been at the heart of the CCM’s philosophy*. Today more than ever, the entire team of cardiologists, anesthesiologists and vascular surgeons, and works together to provide every single patient with the best diagnosis, therapy and medical outcome possible.
The objective of the partnership between CCM and Siemens is to establish and disseminate clinical know-how, optimize processes as well as create innovative treatment concepts. The upcoming projects will concentrate on clinical solutions that focus on individual disease patterns and include the entire clinical workflow. The Clinical Competence Center Cardiology of Siemens coordinates these direct interactions in the clinical field. The mutual findings will be incorporated in future developments by Siemens.
“To be nominated Siemens European Reference Center is not only an honor for us, it also allows us to advance the findings of our years of effort, that is in the diagnosis and therapy for cardiovascular disease and move on to new, extraordinary paths", says Professor Vincent Dor, CEO of CCM. “We are delighted that our excellent cooperation with Siemens for the past 25 years will be further strengthened by this strategic partnership.”
“The outstanding ranking CCM holds in the field of cardiovascular diseases is further emphasized by naming CCM a “Siemens European Reference Center Cardiovascular Medicine“, says Tom Miller, CEO of the Customer Solutions Division at Siemens Healthcare. “Professor Dor and the entire team of physicians at CCM treat the disease pattern of a patient across disciplines. The effective diagnostic and therapeutic process using imaging technologies and incorporating them into efficient processes plays a central role. Siemens has been successfully supporting CCM for more than 25 years with the company’s systems and know-how.”
Centre Cardio-Thoracique de Monaco (CCM): Since its forecast in 1984, physicians and managers of CCM have organized, with Siemens, their scheduled and anticipated medical equipment for this hospital devoted to treat all types of patients and diseases in the field of cardio-thoracic and vascular pathologies.
Two, of the main reasons of successes and satisfactions, were:
1. Since 1990, the realization of a hybrid angio-surgical room cath-lab,
2. Since 2002, the complement of non invasive diagnostic facilities by a “cardiologist driven” MR consol
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 48,000 employees worldwide and operates around the world. In fiscal year 2009 (to September 30), the Sector posted revenue of 11.9 billion euros and profit of around 1.5 billion euros.
Novel PET imaging agent could help guide therapy for brain diseases
03.04.2018 | Society of Nuclear Medicine and Molecular Imaging
New Computer Architecture: Time Lapse for Dementia Research
29.03.2018 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
20.04.2018 | Physics and Astronomy
20.04.2018 | Interdisciplinary Research
20.04.2018 | Physics and Astronomy